Arcadia Biosciences Balance Sheet - Quarterly (NASDAQ:RKDA)

Add to My Stocks
$0.97 $0.07 (6.73%) RKDA stock closing price Feb 17, 2017 (Closing)

The financial analysis of a company involves interpreting the income statement, balance sheet and cash flow statements of the company to draw insights like we've done in our Arcadia Biosciences stock analysis. A balance sheet can help evaluate the financial performance of a company. Ratios like return on total assets and current ratio, which also uses cash on hand can be used to measure the operating efficiency of a firm, and can be used to conduct a more accurate Arcadia Biosciences stock analysis. A company releases its balance sheet every quarter along with its quarterly results. The Arcadia Biosciences balance sheet for 2016-Q3 shows total assets of $61.58M. Arcadia Biosciences revenue was $1.08M and Arcadia Biosciences operating cash flow was $-12.77M for the same quarter. View Arcadia Biosciences quarterly results to get the balance sheet details for the latest & last 40 quarters data..

show more
Annual
Quarterly
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec. 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2
Cash10.47M27.36M29.54M23.97M62.96M80M11.27M16.57M--
Marketable Securities43.41M26.87M20.65M26.27M11.29M-----
Receivables0.24M0.26M0.69M0.78M1.11M0.35M0.32M1.42M--
Inventory0.36M0.3M0.31M0.29M0.59M0.57M0.52M0.42M--
Raw Materials------1.06M---
Work In Progress----------
Finished Goods------1.56M---
Notes Receivable----------
Other Current Assets1.18M1.39M1.33M0.69M0.67M0.7M0.25M0.27M--
Arcadia Biosciences Total Current Assets
55.67M56.19M52.53M52.01M76.64M81.63M12.37M18.69M--
Property Plant & Equipment---5.24M---5.38M--
Accumulated Depreciation---4.65M---4.65M--
Arcadia Biosciences Net Property Plant & Equipment
0.58M0.63M0.65M0.58M0.59M0.63M0.66M0.72M--
Investment & Advances3.47M6.91M14.9M19.74M0.5M0.5M0.5M0.5M--
Other Non-Current Assets1.83M1.87M1.83M1.86M2.13M2.1M2.1M2.14M--
Deferred Charges----------
Intangibles----------
Deposits & Other Assets0.02M0.09M0.17M0.02M0.1M0.11M3.78M2.81M--
Arcadia Biosciences Total Assets
61.58M65.7M70.1M74.24M79.97M84.98M19.42M24.88M--
Notes Payable-5.6M4.56M-------
Accounts Payable2.61M2.57M2.79M2.42M3.97M4.67M3.38M3.19M--
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses----------
Income Taxes Payable----------
Other Current Liabilities1.21M1.5M1.36M1.02M3.28M3.65M4.31M2.46M--
Arcadia Biosciences Total Current Liabilities
3.82M4.07M4.15M3.45M10.89M11.78M12.05M11.26M--
Mortgages----------
Deferred Taxes/Income2.17M2.31M2.49M2.63M2.78M2.93M3.07M3.63M--
Convertible Debt----------
Long-Term Debt25.07M25.02M24.97M24.93M19.46M19.34M8.58M8.86M--
Non-Current Capital Leases----------
Other Long-Term Liabilities3M3M3M3M3M3M3M3M--
Arcadia Biosciences Total Liabilities
34.07M34.42M34.62M34.01M36.14M37.06M26.71M26.77M--
Minority Interest----------
Preferred Stock------84.57M82.88M--
Common Stock Net0.04M0.04M0.04M0.04M0.04M0.04M----
Capital Surplus173.31M172.91M172.58M172.22M171.85M171.33M27.89M29.2M--
Retained Earnings-145.84M-141.66M-137.11M-131.92M-128.06M-123.45M-119.77M-113.97M--
Treasury Stock----------
Other Liabilities-0.01M-0.01M-0.03M-0.11M------
Arcadia Biosciences Shareholders Equity
27.51M31.28M35.47M40.22M43.83M47.92M-7.29M-1.88M--
Arcadia Biosciences Total Liabilities & Shareholders Equity
61.58M65.7M70.1M74.24M79.97M84.98M19.42M24.88M--
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Balance sheet for another ticker

Apart from balance sheet items, an investor would do well to keep track of the Arcadia Biosciences stock price by looking at Arcadia Biosciences historical stock prices. One can compare PE with industry average by looking at the Arcadia Biosciences PE ratio chart. The common balance sheet items are:
  • Assets: RKDA total assets, which was at $61.58M for 2016-Q3 is a balance sheet item representing value of what Arcadia Biosciences owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities or obligations comprise of current liabilities that include short term loans, amounts payable to suppliers, or any other outstanding payments including long term liabilities that take into account long term loans for funding large projects. The total liabilities for Arcadia Biosciences is $34.07M. Shareholders' equity comes under liabilities as it is money the company owes the holders of RKDA stock.
.

Arcadia Biosciences Balance Sheet - Key Ratios

Current ratio
14.57
Debt to Equity ratio
0.91
Asset Turnover
ratio
0.07
receivables turnover
ratio
6.49
PB ratio (
price to book ratio
)
1.2070